Berenberg raised the firm’s price target on Zealand Pharma to DKK 1,080 from DKK 815 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand sees body weight reductions up to mean 8.6% with high dose petrelintide
- Zealand Pharma announces positive CHMP opinion for dasiglucagon
- Zealand initiated with Overweight at Cantor ahead of FDA approvals
- Zealand Pharma initiated with an Overweight at Cantor Fitzgerald
- Zealand Pharma upgraded to Hold from Sell at Danske Bank